62

VIRGINIA JOURNAL OF SCIENCE

each stream ecosystem may be impacted by land use and intensified human expansion.
According to the fall macrobenthic results, nearly all sites saw an increase in %EPT,
except for Massaponax 208 and Ni Route 1. Even though both Massaponax Creek and
the Ni River are under EPA legal limits for phosphate and nitrate concentrations, the
phosphate levels usually rose in summer on the Massaponax and winter for the Ni,
while nitrates peak during the winter and spring for both streams. TDS increased during
the summer and then declined, as precipitation rates fell. Massaponax Creek has higher
TDS than the Ni, but that is reversed for TSS. Fecal coliform levels greatly decreased
from summer into winter and fall, with both streams remaining under legal limits. This
speaks to the recovery of the streams, resulting from repaired sewer lines and decreased
erosion risks in surrounding areas specifically near Massaponax Creek. Due to the
majority increase in %EPT, decreased concentration of nitrates and phosphates, and
reduced fecal coliform levels, the Ni River and Massaponax Creek have generally seen
an improvement in overall health.

M edical Sciences
THE ACTIVATION STATUS OF RHEB IN PEMETREXED TREATED HUMAN
CANCER CELLS. C. M. Bell, S. Agarwal & R. G. Moran, Dept. of Pharmacology &
Toxicology, Virginia Comm. Univ., Richmond, VA 23298. Rheb (Ras homolog
enriched in brain) is a small GTPase essential for activating mTORC1 (mammalian
target of rapamycin complex 1) when loaded with GTP. mTORC1 activation increases
cell growth by promoting protein synthesis and lipogenesis. Tuberous sclerosis protein
2 (TSC2) negatively regulates mTORC1 by stimulating the GTPase activity of Rheb.
Pemetrexed (PTX) is a multi-targeted antifolate drug that suppresses tumor growth by
obstructing folate metabolism and indirectly activating AMP activated kinase (AMPK).
AM PK-activators inhibit cell growth by activation of TSC2 and deactivation of the
mTORC1-partner protein, Raptor. W e have shown that PTX treatment does not
increase the activating phosphorylation of TSC2, but that mTORC1 activity is still
significantly decreased. Further, we have also shown that in cells null for p53, more
Rheb is associated with Raptor and mTORC1 activity is increased. Thus, two methods
have been developed to measure the levels of Rheb-bound nucleotide. Coupled
enzymatic assays using nucleoside diphosphate kinase were employed to convert GTP
to ATP, and the ATP quantified in a luciferase assay. Corresponding GDP was
converted to ã3 2 P-GTP and quantified by reverse phase-HPLC and liquid scintillation
counting. Alternatively, cells were metabolically labeled with 3 2 P orthophosphate and
the Rheb-bound nucleotides resolved by TLC. These two methods show the levels of
Rheb-GTP to be increased in p53 null cells and surprisingly slightly increased in
AICAR or PTX treated cells. Further studies aim to elucidate these data, specifically
by assaying subcellular compartments of the cell for Rheb activation.
T O W A R D S U N D E R ST A N D IN G M O LE C U LA R IN T E R A C T IO N S O F
ETHYLENEDIOXY COUNTERPARTS OF MDMA AND METHYLONE AT hDAT.
F. T. Sakloth1 , F. Del Bello1 , R. Kolanos1 , J. Partilla2 , P. D. Mosier1 , M. H. Baumann 2
& R. A. Glennon1 , 1 Department of Medicinal Chemistry, VCU, Richmond, VA 23298
and 2 National Institutes of Health, NIDA, Baltimore, MD 21224. MDMA (“Ecstasy”)
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and its â-keto analog, methylone (MDMC), are controlled (Schedule I) substances that
are popular recreational drugs. They act as releasing agents at dopamine and/or
serotonin transporters (DAT and/or SERT). The ethylenedioxy counterparts of MDMA
(EDMA) and MDMC (EDMC) are found on the “street” and could represent a potential
abuse problem, but there is little information regarding their actions. The goals of this
project are to 1) examine these ethylenedioxy analogs at DAT using in vitro
(synaptosomal) release assays, and 2) construct homology models of hDAT using the
crystal structure of D. melanogaster followed by docking studies to determine if
differences in potencies might be explained by interactions at DAT. Release data
showed that (?)EDMA and (?)EDMC are 8- and 4-fold less potent, respectively, than
MDMA (IC 5 0 =75 nM) and M DMC (IC 5 0= 133 nM) and that S-EDMA (IC 5 0 =276 nM)
is 50-fold more potent than R-EDMA. Modeling studies suggest that potentially
unfavorable interactions of the ethylenedioxy group of EDMA (especially its R-isomer)
with Ser149 might explain its lower potency at DAT. Additionally, the difference in the
potency of MDMA and EDMA, and of S-MDMA and S-EDMA over their lowerpotency R-isomers seems to be explained by the energy penalty for the binding of the
ligands at DAT. EDMA and EDMC are unlikely to be as much of an abuse problem as
their methylenedioxy counterparts. [Supported by NIH grant DA 033930.]
ALTERATIONS TO THE SYNAPTIC TRANSCRIPTOME IN RESPONSE TO
ETHANOL-INDUCED SENSITIZATION. Megan A. O’Brien & Michael F. Miles,
Department of Pharmacology & Toxicology, Virginia Commonwealth University,
Richmond VA 23298. It is well established that mRNA can be transported to neuronal
distal processes, where it can undergo localized translation regulated in a spatially
restricted manner in response to stimulation, potentially playing a role in synaptic
plasticity that results in long-term adaptive brain responses. In order to investigate our
hypothesis that ethanol behavioral sensitization results, at least in part, from alterations
in the trafficking of mRNAs to distal processes, we profiled the synaptic transcriptome
utilizing two distinct methodologies: mRNA microarray and RNA-Seq. By using two
independent techniques, which employ different molecular principles, we were able to
validate data processing schemes as well as differential expression results. W e found
that there was a significant overlap between these analyses (p-value < 1.0E-16), where
70% of the genes determined by RNA-Seq to be differentially expressed between the
synaptic and cytosolic fractions were also deemed significant by microarray analysis.
Expression data was then analyzed to identify 229 synaptically targeted candidate
genes differentially expressed as a result of ethanol treatment. Examination of gene
expression patterns revealed a number of genes whose levels were altered in response
to acute ethanol, but habituated in response to repeated, sensitizing ethanol treatment.
Functional over-representation analysis revealed enrichment for genes associated with
the endoplasmic reticulum and the extracellular matrix. Support provided by NIAAA
grants U01AA016667, P20AA017828, and F31AA021035.
INHIBITION OF MONOACYLGLYCEROL LIPASE: THERAPEUTIC POTENTIAL
W ITH LIMITED CANNABIMEMTIC EFFECTS. B. Ignatowska-Jankowska 1 , M.
Mustafa1 , S. Ghosh1 , M. Niphakis2 , R. Abdullah1 , J. W ilkerson1 , J. W iley3 , B. Cravatt2 ,
& A. Lichtman1 , 1 Dept. of Pharmacology & Toxicology, VCU, 2 The Skaggs Institute
for Chemical Biology & Dept. Of Chemical Physiology, TSRI, 3 Research Triangle
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Institute, RTP. The endocannabinoid 2-arachidonoyl glycerol (2-AG) plays a role in
many physiological processes, and it is degraded by monoacylglycerol lipase (MAGL).
W hile increase in 2-AG signaling by preventing its degradation is a promising strategy
in treatment of pain, and several other disorders, its function and effects in vivo remain
unclear. MJN110 is a novel, selective inhibitor of M AGL that allows for examination
of increase in 2-AG, without affecting other endocannabinoid levels. In the present
study we tested MJN110 in a murine model of inflammatory pain induced by
carrageenan as well as tetrad and drug discrimination assays. M JN110 showed high
efficacy and potency to produce anti-allodynic and anti-edematous effects in the pain
model [ED50 (95% confidence intervals, C.I.)=0.26 (0.14-0.47) mg/kg]. MJN110 at
high doses produced antinociception and increased locomotor actiovity, but did not
induce catalepsy or hypothermia. In drug discrimination assay, MJN110 fully
substituted for CP55,940, [ED50 (95% C.I.)=0.84 (0.69-1.0) mg/kg], indicating that it
produced cannabimimetic interoceptive effects. The antinociceptive effects of MJN110
in the carrageenan assay were 2.4 (1.6-4.4) [potency ratio (95% C.I.)] more potent than
in the drug discrimination. MJN110 significantly elevated 2-AG but not other
endocannabinoid levels in the brain. Findings are in agreement with in vitro research
showing that MJN110 is highly potent and selective MAGL inhibitor in vivo. The
results indicate that MAGL inhibition with MJN110 reverses inflammatory pain at
lower doses than those that produce cannabimimetic side effects.
THE ABILITY TO MODULATE AND INFLUENCE IMMUNE CELLS TO IMPACT
TUMORS IN DIVERSE CONTEXTS. Se W . Jeong & Timothy N. J. Bullock,
Department of Pathology, University of Virginia, Charlottesville, VA 22908.
Metastatic melanoma has one of the poorest prognoses for patients as the median
survival ranges from six to nine months. Nonetheless, there has been significant
progress made over the past several years in which immunotherapy have contributed
considerably. Celldex Therapeutics has developed a fully human monoclonal antibody
which targets CD27 (CDX-1127), a potent costimulatory molecule that can drive
lymphocyte proliferation and expansion. CDX-1127 is able to mimic CD70, which
serves as the ligand for CD27. The interaction thus creates an appropriate T cell
receptor signal to drive T cell activation. There is a significant interest in using CD27
as a therapeutic model as data have shown strong evidence of anti-tumor response and
immunity in recent studies. W hereas Celldex administers clinical trials, our
immunology laboratory receives patient samples throughout the treatment for flow
cytometry analysis of key immunological molecules, identifying B and T cells and to
enumerate specific subsets of T cells. One of the more interesting results from CDX1127 phase I clinical trial is that the MHC class II surface receptor HLA-DR expression
increases in majority of the patients, which suggests the immune system is becoming
more active upon treatment. In addition, regulatory T cells significantly decreased after
the CDX-1127 treatment further implicating the potential for CD27 target therapy for
melanoma patients
DIACYLGLYCEROL LIPASE BETA: NEW EVIDENCE FOR INFLAMMATORY
AND NEUROPATHIC PAIN RELIEF IN M ICE. J. W ilkerson 1 , S. Ghosh 1 , K. Hsu 2 ,
B. Cravatt2 & A. Lichtman1 ,1 Dept. of Pharmacology & Toxicology, Virginia
Commonwealth University, Richmond, VA 23298, 2 The Skaggs Institute & TSRI, La
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Jolla, CA 92037. Diacylglycerol lipase (DAGL), the enzyme responsible for
generation of 2-arachidonylglycerol, represents a component of the endogenous
cannabinoid system as a potential therapeutic target to treat pain. As DAGL-â
inhibition leads to decreases in lipopolysaccharide (LPS)-induced prostaglandins &
proinflammatory cytokines, we hypothesized that inhibition of this enzyme will reverse
nociceptive behavior in a mouse model of inflammatory pain. W e tested DAGL-â (-/-)
& wild type (W T) mice treated with the selective DAGL-â inhibitor KT109 in the
inflammatory model of intraplantar LPS (2.5 ìg) pain. LPS produced robust increases
in sensitivity to light mechanical touch, or allodynia, & increased thermal sensitivity,
or thermal hyperalgesia in W T mice. Systemic & local intraplantar injection of KT109
reversed LPS-induced allodynia in a time- & dose-dependent manner. DAGL-â (-/-) mice
displayed reductions in LPS-induced allodynia. KT109 administration into the
contralateral paw did not reduce LPS-induced hyperalgesia or allodynia, suggesting that
these effects occurred locally. Neither intrathecal nor intracerebroventricular injection
of KT109 reversed LPS-induced allodynia, consistent with a peripheral site of action.
These findings suggest DAGL-â inhibition reverses the negative sensori-discriminative
state often associated with inflammatory pain.
TOLERANCE TO THE RATE-DECREASING EFFECTS OF CP55,940 DEVELOPS
IN MURINE INTRACRANIAL SELF-STIMULATION. T. W . Grim, J. M.
W eibelhaus, S. S. Negus & A. H. Lichtman, Dept. of Pharmacology & Toxicology,
Virginia Commonwealth University, Richmond, VA 23298. Although not currently
abused, CP55,940 is a synthetic cannabinoid that possesses many similarities to abused
“non-classical” cannabinoids such as CP47,497 and its C8 homolog in terms of
increased potency and efficacy relative to Ä9 -tetrahydrocannabinol (THC). Thus
CP55,940 was selected as an archetypal synthetic cannabinoid to probe the effects of
acute and chronic effects of cannabinoids on operant responding for intracranial selfstimulation (ICSS) of the medial forebrain bundle in C57BL6/J mice. Acutely,
CP55,940 (0.3-1.0 mg/kg) produced a dose-related significant depression of operant
responding for ICSS (ED 50 value (95% confidence limits) = 0.18 (0.12-0.26) mg/kg).
The CB1 receptor antagonist, rimonabant (3.0-10.0 mg/kg; s.c.), significantly
attenuated the rate-decreasing effects of CP55,940, indicating CB1 receptor mediation.
Repeated administration of CP55,940 (0.3 mg/kg, s.c., q.d. for 7 days) resulted in a
significant attenuation to the drug's rate-decreasing effects, indicative of tolerance.
There were no measurable spontaneous withdrawal effects for CP55,940 under these
experimental conditions. Collectively, these data suggest that the abuse liability of
synthetic cannabinoids occurs through a distinct mechanism from other drugs of abuse
(e.g., cocaine) that act through the classic mesolimbic pathway. Nevertheless, operant
responding for ICSS represents a novel approach to investigate the impact of acute and
chronic administration of cannabinoids on reward-mediated behavior.
DISCOVERY OF SMALL MOLECULE INHIBITORS OF PSAA, A POTENTIAL
TARGET FOR STREPTOCOCCUS PNEUMONIAE. Ahmad J. Obaidullah 1 , Hardik
I. Parikah1 , Todd Kitten2 & Glen E. Kellogg1 , 1 Department of Medicinal Chemistry,
Virginia Commonwealth University, Richmond, VA 23298 & 2 Philips Institute for Oral
Health Research, Virginia Commonwealth University, Richmond, VA 23298. Due to
development of multidrug resistance in Streptococcus pneumoniae over the last few
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years, research has begun to define new drug targets for pneumonia therapy. Multiple
experiments with Streptococcus pneumoniae performed by different research groups
have identified a lipoprotein PsaA that is important for pneumonia virulence and is also
a promising target for pneumonia therapy. PsaA is a high-affinity manganese (Mn)
transporter that is required not only for pneumonia virulence, but also for aerobic
growth of Streptococcus pneumoniae in serum. W e have employed computer modeling
and computational chemistry to virtually screen a small-molecule database for
inhibition of PsaA function by targeting the metal binding pocket, performing receptorbased virtual screening, molecular docking to identify potential inhibitors of PsaA
function, and scoring. W e have developed an assay for screening compounds, including
the use of a PsaA mutant, testing of multiple compounds, and identification of small
numbers of compounds that inhibit Streptococcus pneumoniae growth at concentrations
less than 20 µM. W e will next experimentally test the compounds’ effect on Mn uptake
and their PsaA dependence. Supported by American Heart Association grant
13GRNT16100010 to TK.
VARIATION IN TIMING OF HEART SOUNDS RELATIVE TO ECG EVENTS IN
COLLEGE STUDENTS. Harold J. Grau, Department of Molecular Biology &
Chemistry, Christopher Newport University, Newport News, VA 23606. Students in
our Human Anatomy & Physiology II lab course performed an activity that included
simultaneous recordings of electrocardiograms (ECG) and heart sounds. The two basic
heart sounds occur first at the closure of the atrioventricular (AV) valves (S1), and then
at the closure of the semilunar valves (S2). AV closing occurs just at the beginning of
ventricular systole, which follows the depolarization of the ventricles, indicated by the
QRS complex of the ECG. The second sound occurs just after the ventricles begin
relaxing (diastole), which follows the repolarization indicated by the T wave of the
ECG. Data were collected from about 2 dozen subjects, both male and female, between
ages of 20 – 22 years old. The delay between peak R – S1 ranged from 9 – 55 ms, with
most falling into two “clusters” of 22 – 27 ms, and 41 – 47 ms. The delay between peak
T – S2 ranged from 69 – 136 ms, with no obvious “clusters”. The time between peak
R – peak T varied from 227 – 309 ms, and correlated with both the peak R – S1 and
peak T – S2 delays. However, the peak R – S1 delay does not correlate with the peak
T – S2 delay. The time between the two sounds (S1 – S2) varied from 307 – 382 ms,
and correlates positively with the ECG correlates of systole (peak R – peak T).
QSAR STUDY OF 4-SUBSTITUTED METHCATHINONE ANALOGS AT DAT
AND SERT. F. T. Sakloth1 , J. Partilla2 , R. Kolanos1 , M . Barnier1 , R. Vekariya 1 , P. D.
Mosier1 , M. H. Baumann2 , & R. A. Glennon1 , 1 Department of Medicinal Chemistry,
Virginia Comm. Univ., Richmond, VA 23298 & 2 National Institutes of Health,
National Institute of Drug Abuse, Baltimore, M D 21224. Methcathinone (MCAT)
analogs are a popular class of designer drugs and, due to their abuse potential, about
15 are now controlled as US Schedule I drugs. MCAT and its simple 4-substituted
analogs act primarily as dopamine and/or serotonin releasing agents in release assays
using rat synaptosomes. The goals of this project were: 1) to perform QSAR
(quantitative structure-activity relationship) studies of 4-substituted MCAT analogs
(n=6) to determine whether action at the dopamine and serotonin transporters (DAT
and SERT, respectively) and selectivity might be explained on the basis of their steric
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properties, and 2) to construct homology models of the human DAT and SERT using
the crystal structure of Drosophila melanogaster followed by docking studies to
identify how steric character might be explained on the basis of interactions with the
two transporters. QSAR studies indicated that increasing length/volume of the 4position substituent is favorable for SERT action whereas the opposite is favored for
DAT. Selectivity for SERT over DAT was found to be highly correlated with volume,
length and maximum width (r > 0.9). Modeling studies indicated an unfavorable
interaction at hDAT, which was not seen at hSERT, in the binding pocket associated
with the 4-position substituent. These differences in the binding pockets of the two
transporters could explain differences in selectivity. 4-Position steric factors seemingly
regulate DAT/SERT selectivity. [Supported by DA DA033930.]
QUANTIFICATION OF HUMAN OSTEOPONTIN, A CANCER BIOMARKER
PROTEIN, FROM PLASMA BY MICROFLOW LC-MS/MS. M . Faria 1 , M. S.
Halquist1 , M. Yuan2 , W . Mylott Jr.2 , R. G. Jenkins2 , & H. Thomas Karnes1 , 1 Virginia
Comm. Univ., Richmond, VA 23298, 2 PPD Inc, Richmond, VA 23230. Human
osteopontin is a secreted plasma protein which is elevated in various cancers and is
indicative of poor prognosis. It mainly operates through its integrin binding site
159
RGDSVVYGLR. A method was developed and validated for quantitative
measurement of human osteopontin from plasma using microflow LC-MS/MS. In silico
studies were carried out using online Protein Prospector software and Basic Local
Alignment Search Tool to obtain a signature peptide. An immunoaffinity coupled LCMS/MS method was developed. The applicability of the validated method was
demonstrated by quantification of OPN from plasma samples obtained from 10 healthy
individuals and 10 breast cancer patients. A biologically relevant tryptic peptide
‘GDSVVYGLR’ which is unique to human osteopontin was identified and used as a
signature peptide for this method. The method was validated over a linear range of 25600 ng/mL for human osteopontin. The plasma OPN concentrations in healthy
individuals ranged from 38-85 ng/ml with a mean concentration of 55±15 ng/ml. A 212 fold increase in osteopontin concentrations, ranging from 85-637 ng/ml, were seen
in breast cancer patient samples. In conclusion, microflow LC-MS/MS can be used for
accurate and precise quantitative bioanalysis of proteins. This validated LC-MS/M S
method can be used in clinical settings for measuring osteopontin levels from plasma.
QUINAZOLINES AS NOVEL HUMAN OCT3 INHIBITORS: STRUCTURE
ACTIVITY STUDIES. Malaika D. Argade1 , Xiaolei Pan2 , Kavita A. Iyer 1 , Douglas
Sweet2 & Ma³gorzata Dukat1 , 1 Department of Medicinal Chemistry, & 2 Department of
Pharmaceutics, Virginia Commonwealth University, Richmond VA 23298. Globally,
depression affects 20% of the population with half being refractory to current therapies.
Depression is associated with low synaptic levels of the neurotransmitters serotonin (5HT) and/or norepinephrine (NE) regulated by high-affinity, low-capacity transporters,
SERT and/or NET (uptake-1). Recently, low-affinity, high-capacity transporters,
Organic Cation Transporters (OCT1-3; uptake-2) have been identified as an alternative
mechanism in regulation of synaptic 5-HT and NE levels. Previously, we reported that
2-amino-6-chlorodihydroquinazoline (A6CDQ) showed antidepressant-like effects in
the mouse tail suspension test. A6CDQ lacks affinity at SERT (K i > 10,000 nM), but
inhibits hOCT3 (IC 5 0 = 3.9 ìM). To determine whether the 6-chloro group exerts its
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effect via its electronic or lipophilic character, we synthesized the 6-methyl analog
(A6MDQ) that bears an electron-donating group as opposed to the electronwithdrawing chloro group. Methyl and chloro groups possess similar lipophilic (i.e.,
ð = 0.56; 0.71, respectively), but opposite electronic character. A6MDQ inhibited
hOCT3 expressed in HEK293 cells (IC 5 0 = 1.6 ìM). This suggests that the lipophilic
character of the substituent plays an important role in the inhibitory actions of hOCTs.
W e generated the first 3-D graphics model of hOCT3 using the inorganic phosphate
transporter (PDB:4J05) as a template. The molecular modeling studies agreed with the
experimental results obtained since the 6-methyl analog utilizes a similar binding mode
as the 6-chloro analog, thereby validating the model.
QSAR AND MOLECULAR MODELING STUDIES ON ARYLGUANIDINES AS
á7 nAChR NAMs. O. I. Alwassil1 , S. Khatri2 , M. K. Schulte 2 & M . Dukat1 ,
1
Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond,
VA 23298, 2 Department of Pharmaceutical Sciences, University of Sciences,
Philadelphia, PA 19104. There is ample literature evidence that á7 neuronal nicotinic
acetylcholine receptors (nAChRs) might play a role in the treatment of Alzheimer’s
disease. Previously we reported that meta-chlorophenylguanidine (mCPG; 1) and its Nmethyl analog 2, developed in our laboratory, exert negative allosteric modulator
(NAM) actions at á7 nAChRs expressed in HEK cells (IC 5 0 = 8 and 1.3 µM,
respectively). Initial SAR and 3D graphics models suggested different binding modes.
Thus, two series of analogs (n = 16) based on 1 and 2 were synthesized and evaluated
for functional activity in two-electrode voltage clamp assays using frog oocyteexpressed á7 nAChRs (IC 5 0 value range = 21 – 118 µM; 12 – 125 µM, respectively).
Quantitative structure–activity relationship (QSAR) studies support our initial findings
that the two series of NAMs interact in a different manner at á7 nAChRs because
parallel structural changes did not result in parallel shifts of activity and there is a lack
of significant correlation between the activities of the two series (r = 0.474).
Furthermore, the studies indicated that electronic (?; r = 0.820) properties might be
important at the meta-position of 1 analogs and shape (B 1; r = 0.927) for the 2 series
for their NAM actions, and support our proposed 3D graphics model. Supported in part
by the Virginia Center on Aging (Award No. 12-2).
DECONSTRUCTION OF RISPERIDONE – HOW FAR IS TOO FAR? S. A.
Gaitonde1 , J. Younkin2 , D. E. Logothetis2 , R. A. Glennon1 & M. Dukat1 , 1 Departments
of Medicinal Chemistry and 2 Physiology & Biophysics, VCU, Richmond, VA 23289.
Ketanserin (competitive antagonist) and the antipsychotic agent risperidone (an inverse
agonist), though structurally similar, differ in their functional action at 5-HT 2 A
receptors. This study probes this disparity and attempts to envisage the minimal
structural features that confer risperidone with its action. The structure of risperidone
was deconstructed to give 4 analogs: 6-fluoro-3-(piperidin-4-yl)benzisoxazole (FBP),
6 -flu o r o -3 -( 1 - m e t h y l - p i p e r i d i n - 4 - y l ) b e n z i s o x a z o l e ( F B P M ) , 4 - [ ( 4 - ( 6 fluorobenzisoxazol-3-yl)piperidin-1-yl)-1-(piperidin-1-yl)]butan-1-one (FBPC) and 6fluoro-3-[(1-(4-piperidin-1-yl)butylpiperidin-4-yl)]benzisoxazole (FBPS). The analogs
were synthesized and functional action examined using two-electrode voltage clamp
techniques (Xenopus oocytes expressing 5-HT 2 A receptors and Kir3.4 channels). FBPC
and FBPS were partial agonists (60% and 62% activity compared to 5-HT,

Virginia Journal of Science, Vol. 65, No. 1, 2014

https://digitalcommons.odu.edu/vjs/vol65/iss1

PROCEEDINGS 92ND ANNUAL MEETING

69

respectively) whereas FBP and FBPM were competitive antagonists (74% and 100%
inhibition of 5-HT activity, respectively). A 3D-graphics model of the h5-HT 2 A receptor
using the crystal structure of the h5-HT 2 B receptor (PDB 4IB4) as template showed that
ketanserin and risperidone differ in their binding mode at TM5 in forming hydrogen
bonds with Ser239 and Ser242, respectively, and that risperidone and its analogs
displayed similar binding modes and form a bidentate interaction with Ser159 (TM3);
ketanserin did not. Based on the modeling results, it can be concluded that, at present,
our model cannot distinguish between the observed functional actions. But, inverse
agonist action of FBP/FBPM remains to be established.
AN ASSOCIATION BETW EEN THE DEPRESSION AND SYSTEM IC
INFLAMMATION IN NHANES POPULATIONS.
Rachel Smith 1 ,2 , Maria
1 ,2
1 ,2
1 ,2 1
Stepanova , Ancha Baranova , & Aybike Birerdinc , Betty and Guy Beatty Center
for Integrated Research, Inova Health System, Falls Church, VA 22042 and Center for
the Study of Chronic Metabolic Diseases, George Mason University, Fairfax, VA
22030. A population-based study was conducted to determine the association of
individuals with chronic diseases and depression from five cycles of the National
Health and Nutrition Examination Survey (NHANES) data. The presence of depression
was determined from a depression screener questionnaire, while the presence of chronic
diseases were gathered from medical conditions questionnaires (3,751 and 26,225
subjects respectfully). Interestingly, individuals with depression and those with multimorbidity had the same statistically significant increased inflammatory markers as
assessed by HOMA scores, C-reactive proteins, white blood cell counts, and
percentages of segmented neutrophils and glycohemoglobin (p<0.05). Additionally,
both had statistically significant decreased levels of HDL-cholesterol, lymphocyte
percentages, and monocyte percentages (p<0.05). The increased inflammatory markers
suggest that low-grade chronic inflammation may be the connection between
depression and chronic diseases in these individuals. Examining these inflammatory
markers may be used as predictors in the treatment of patients.
MITOCHONDRIAL HAPLOGROUP ASSESSMENT IN OBESE PATIENTS W ITH
NAFLD. Kianoush Jeiran1 , Rohini Mehta2 , Ancha V. Baranova 1 , & Zobair Younossi2 ,
1
School of Systems Biology, George Mason University, Manassas, VA 20110 and
2
Claude Moore Health Education and Research Center, Inova Fairfax Medical Campus,
Falls Church, VA 22042. Liver disease is considered a significant health problem
worldwide nowadays. Among distinct disease, non-alcoholic fatty liver disease
(NAFLD), which is widely considered the hepatic manifestation of the metabolic
syndrome, is a complex multifactorial disease trait where environment and genetic
variations interact to determine the wide spectrum of disease progression. One of the
key challenges is to predict the progression of NAFLD; mitochondrial genotyping may
serve as an indicator of increased susceptibility to progressive NAFLD. In this study
the association of sequence variations (haplogroups and indels) in control loop of
mitochondria within 86 patients with biopsy-proven NAFLD and metabolic syndrome
was investigated. After extracting DNA from whole blood cells and amplifying control
loops by PCR and sequencing the control region; samples have been categorized within
11 haplogroups (H, I, J, K, L, M, T, U, V, W , and X). Liver biopsy pathology has
revealed that 64 (74.4%) patients diagnosed with NAFLD and 22 (25.6%) patients had
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normal biopsy. Moreover, 80.8% of patients with Non-L mtDNA haplogroups progress
to NAFLD, but only 38.8% of patients with L haplogroup diagnosed with NAFLD
which proves that obese patients with L haplogroup are much less susceptible to
develop non-alcoholic fatty liver comparing to other mtDNA genotypes.
Posters
REGULATION OF SEROTONIN TRANSPORT FUNCTION AND CELL SURFACE
EXPRESSION BY BRAIN-DERIVED NEUROTROPHIC FACTOR.
J.
Rajamanickam, K. N. Naidu, L. Jayanthi, & S. Ramamoorthy, Dept. of Pharm. & Tox.,
VCU, Richmond VA 23298. The serotonin (5-HT) transporter (SERT) maintains the
level of serotonin in the synaptic cleft by reuptaking released 5-HT into presynaptic
terminals. Dysfunction of SERT leads to several psychiatric disorders like autism,
depression, obsessive-compulsive disorder, and addiction. Selective serotonin reuptake
inhibitors (SSRIs) are specifically target SERT and inhibit 5-HT reuptake in the
treatment of psychiatric disorders. A member of neurotrophin family of proteins, brain
derived neurotrophic factor (BDNF), which binds to Tropomyosine-related kinase B
receptor (TrkB), reduces SSRI mediated inhibition of 5-HT reuptake by increasing
SERT activity. Current study was aimed to understand the regulation of activity and
expression of SERT by BDNF and TrkB. BDNF treatment of HEK 293 cells coexpressing SERT and TrkB increased the SERT activity parallel with increased surface
level of SERT protein. Kinetic assay revealed increase in Vmax of SERT following
BDNF treatment. BDNF treatment also increased the phosphorylation of endogenous
protein kinases ERK1/2 and Akt in the HEK 293 cells. Treatment of HEK 293 cells
with the inhibitors of ERK1/2 (PD98059) and Akt (Akt inhibitor X – AktX) reduced
the 5-HT uptake in a concentration dependent manner. BDNF treatment reversed the
inhibitory effect of PD98059 but not of AktX on SERT activity. This result indicates
that BDNF may stimulate the 5-HT uptake indirectly through increasing the
phosphorylation of ERK1/2. The overall observations suggest that BDNF regulates
surface expression and function of the serotonin transporters.
COMPARISON OF THE COGNITIVE EFFECTS OF THE NMDA ANTAGONIST
KETAMINE IN ADOLESCENT AND ADULT RATS. M. P. George and K. L.
Nicholson, Department of Pharmacology and Toxicology, Virginia Commonwealth
University, Richmond, VA 23298. Ketamine has been subject to growing rates of
abuse worldwide, particularly in adolescent populations. Previous studies in the
laboratory have shown differences in abuse-related behavioral effects of ketamine in
rats based on age. The current project extends this investigation by comparing the
effects of ketamine on memory in a novel object recognition procedure in male
Sprague-Dawley rats. Activity in a 17 in. x17 in. experimental chamber was recorded
and analyzed using ANYmaze software. Rats underwent two 6-min training periods,
separated by 1 hour, during which two like objects were present in the chamber. After
an hour, one object was replaced with a novel item and rats returned to the chamber for
a 6-min testing period. Time spent in the two zones when the like items were present
was compared to the times when one item was replaced with a novel object. Baseline
performance was determined across three age groups: adolescent (PND34-44), young
adult (PND70-90) and older adult (PND150-180). Subsequently ketamine and cocaine
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were tested in adult rats for disruption of memory retrieval. In baseline tests,
adolescents spent more time in the novel object zone, however due to a high level of
variability, the effect was not significant. Both young and older adult rats demonstrated
evidence of learning with significantly more time spent with the novel object. Cocaine
and ketamine produced dose-dependent disruption of memory retrieval in both groups
of adult rats. The effect of additional habituation and training in adolescent subjects is
being investigated prior to drug testing in this age group.
DEVELOPMENT OF NATURAL CYCLIC PEPTIDE INHIBITORS OF XRCC4/XLF
INTERACTION FOR RADIO-SENSITIZATION OF BREAST TUMOR CELLS. M.
Al Mohaini1 , K. Akopiants1 , E. R. W hite2 , M. C. T. Hartman2 ,3 , & L. F. Povirk 1,3 , 1 Dept.
of Pharm. & Tox., 2 Dept. of Chemistry & 3 Massey Cancer Center, VCU, Richmond,
VA 23298. Breast cancer is the second leading cause of cancer death in women, and
the standard treatment is ionizing radiation combined with surgery and chemotherapy.
Cell death after exposure to radiation results largely from DNA double-strand breaks.
Previous studies showed that many breast tumor cells depend mainly on nonhomologous end joining (NHEJ) for repairing induced DNA damage. XRCC4 and
XLF are two essential interacting proteins in the NHEJ process. A single mutation on
the XLF-binding interface of XRCC4 at M61, F106, E55 or D58 has been shown to
disrupt its interaction with XLF, thus inhibiting NHEJ. Therefore, it is proposed that
small natural cyclic peptides that bind to the XLF interface of XRCC4 near M61 and
F106 can be identified through an mRNA display in vitro selection, and these peptides
will inhibit NHEJ and thereby radiosensitize breast tumor cells. Using mRNA display,
we created a library of a trillion unique cyclic mRNA-peptide fusions. After seven
rounds of in vitro selection, the eluted fusions were cloned and sequenced. Results
showed homology of sequences of five main families (Pep 7.1-7.5), and we have
synthesized representative peptides of these families. Fluorescence polarization studies
showed binding affinities of Pep 7.1 and Pep 7.2 to XRCC4 1 5 7 protein with K D of 16.78
and 18.77, respectively. Furthermore, Pep 7.1 and Pep 7.2 were able to inhibit the
rejoining of a simple restriction-cut plasmid in an extract of patient derived XLF Bus
cells supplemented with XLF protein.
THE ROLE OF P38 NITORGEN-ACTIVATED PROTEIN KINASE MEDIATED
NOREPINEPHRINE TRANSPOTER REGULATION IN COCAINE-INDUCED
BEHAVIOR. P. Mannangatti, K. Narasimha Naidu, M. I. Damaj, S. Ramamoorthy,
& L. D. Jayanthi, Dept. of Pharm & Tox., VCU, Richmond, VA 23298. The
noradrenergic and p38 mitogen activated protein kinase (p38 MAPK) systems have
been implicated in behavioural effects of cocaine. The present experiments were
designed to probe functional interactions between norepinephrine transporter NET and
p38 MAPK by testing the role of p38 MAPK-mediated NET regulation in cocainemediated behaviours. In Experiment 1, mice pre-exposed to i.p. cocaine (15 mg·kg-1,
day 1; 30 mg·kg-1 days 2-4; and no drug, days 5-8) or saline were pretreated with
SB203580 (50-100 µg·kg-1, i.p), before testing for locomotor sensitization in response
to cocaine challenge (15 mg·kg-1, day 9). In Experiment 2, mice were subjected to
unbiased cocaine CPP where mice received 10 mg·kg-1, i.p cocaine for 4 days and on
d a y five re c e iv e d v e h ic le o r S B 2 0 3 5 8 0 4 -[5 -(4 -F luo ro p he nyl)-2 -[4 (methylsulfonyl)phenyl]-1H-imidazol-4-l]pyridine (50-100 µg·kg-1, i.p), and tested for
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preference scores. In Experiment 3, after behavioural testing, NE transport function and
NET expression levels along with phospho-p38 M APK levels were measured in the
prefrontal cortex (PFC) and nucleus accumbens (NAc) of the mice. Pretreatment with
SB203580 selectively interfered with cocaine-induced locomotor sensitization and
CPP. In addition, SB203580 pretreatment blocked cocaine-induced p38 MAPK
activation and the upregulation of NE transport and NET expression in the PFC and
NAc brain regions of the mice. These findings reveal a mediating role for p38 MAPKmediated NE transmission in cocaine-related behaviours.
THE DUAL FAAH/MAGL INHIBITOR SA-57 SERVES AS A DISCRIMINATIVE
STIMULUS. R. Owens1 , B. Cravatt2 , & A. Lichtman1 , 1 Dept. of Pharm. & Tox., VCU,
Richmond, VA 23298, 2 The Skaggs Institute, & TSRI, La Jolla, CA 92037. The drug
discrimination paradigm is a very sensitive assay to infer interoceptive effects of a
variety of psychoactive drugs, including cannabinoids. The phytocannabinoid Ä 9 tetrahydrocannabinol (THC) serves as a discriminative stimulus in rodents via
cannabinoid receptor type one (CB 1) mechanism of action. Simultaneous inhibition of
the endocannabinoid degradative enzyme fatty acid amide hydrolase (FAAH) and
monoacylglycerol lipase (MAGL) produces THC-like effects in this paradigm. More
recently, the development of the dual FAAH/MAGL inhibitor SA-57, which is more
potent at inhibiting FAAH than MAGL, provides a useful tool to investigate the impact
of differentially inhibiting these endocannabinoid degradative enzymes. Mice were
trained to discriminate between the potent synthetic cannabinoid CP55,940 (0.1 mg/kg)
and vehicle in a nose-poke discrimination task (ED 5 0 (95% confidence interval) = 0.34
0.058 - 1.99) mg/kg. SA-57 (10 mg/kg) fully substituted for CP55,940. The
discriminative stimulus effects of both CP55,940 and SA-57 were completely
antagonized by 3 mg/kg rimonabant, indicating a CB 1 receptor mechanism of action.
These findings suggest that SA-57 produces a similar interoceptive stimulus as
CP55,940. Importantly, mice learned to discriminate between SA-57 and vehicle in a
dose-related fashion (ED 50 value = 4.49 mg/kg, 95% CI 3.77 – 5.35 mg/kg). This study
represents the first demonstration that complete blockade of the primary
endocannabinoid degradative enzymes FAAH and MAGL serves as a reliable
discriminative stimulus.
ADIPONECTIN EXPRESSION IN PATIENTS SUFFERING FROM METABOLIC
DISORDERS. Kameron M. Tavakolian & Michael Estep, The Beatty Liver & Obesity
Research Program, Inova, Falls Church, VA 22042, School of Systems Biology,
College of Science, George Mason University, Fairfax, VA 22030. Adiponectin is an
essential adipokine released from adipose tissue with antiatherogenic, anti-diabetic, and
anti-inflammatory properties. Individuals with fatty liver disease show reduced
circulating levels of adiponectin independent of body mass index, which is inversely
correlated to the degree of steatosis and inflammation. The aim of this study was to
measure the expression of adiponectin and its receptor, AdipoR1, in visceral adipose
tissue and its relation to hepatic fibrosis. RNA was extracted from visceral adipose
tissue from a selected cohort of 19 morbidly obese patients using a BIORAD kit. The
iScript cDNA synthesis kit was used and RT-PCR was performed with AdipoQ and
AdipoR1 primers, along with GAPDH and RP2 as endogenous controls. Primers for
the study were designed on NCBI with stringent criteria such that each primer crossed

Virginia Journal of Science, Vol. 65, No. 1, 2014

https://digitalcommons.odu.edu/vjs/vol65/iss1

PROCEEDINGS 92ND ANNUAL MEETING

73

an intron and the deltaG setting minimized hairpin formation and primer dimerization.
No correlation between adiponectin expression and severity of fibrosis was observed,
although a larger sample size would be needed to determine whether adiponectin plays
a role in fibrosis.
HYDROXYMETHYLATION AND ALZHEIMER’S DISEASE: A MAP OF
DYNAMIC REGIONS IN THE DISEASED STATE. R. H. Haraf, M. Baker, J. Davy,
A. Hazy, D. Harrison, N. Taher, and G. Isaacs, Dept. of Biology, Liberty University,
Lynchburg VA 24502. Alzheimer’s Disease (AD) is a neurodegenerative disorder that
is currently responsible for approximately 500,000 deaths per year. Because less than
5% of cases result from a genetic mutation, epigenetic factors are being considered as
a potential cause for the majority of AD patients. Hydroxymethylation, a recently
discovered epigenetic modification to cytosine, has been found to be especially
prevalent and active in the brain. Furthermore, it has been linked to neurogenesis,
neural differentiation, and normal neurological function. For this reason, understanding
the exact role of hydroxymethylation in the brain may shed light on the cause and
pathogenesis of AD, as well as other neurological disorders. This study sought to map
the distribution of hydroxymethylation in the brain of a healthy mouse and a mouse
displaying AD-like characteristics. Using a double transgenic murine model that
developed beta-Amyloid plaques in the brain, hippocampal DNA was tested for the
presence of hydroxymethylation in the promoter regions of genes. Changes in
hydroxymethylation distribution between the healthy and AD mice were mapped,
allowing the determination of 206 specific genes of interest that may be dysregulated
in Alzheimer’s Disease.
THE EFFECTS OF DOXYCYCLINE-INDUCED HIV-1 TAT PROTEIN
EXPRESSION IN MICE ON THE STARTLE REFLEX AND ITS PREPULSE
INHIBITION. R. M. Enga, K. F. Hauser, & P. M. Beardsley, Department of
Pharmacology & Toxicology, Virginia Commonwealth University, Richmond, VA
23298. Motor and behavioral deficits, including deficits of attention, are present in
HIV-associated neurocognitive disorders (HAND) that may, in part, be attributable to
HIV-1 Tat protein expression. Sensorimotor gating is linked to attention, and can be
measured by the acoustic startle response and its prepulse inhibition (PPI). To
determine whether HIV Tat contributes to impaired sensorimotor gating, we tested
doxycycline (DOX)-inducible Tat transgenic mice and C57BL/6J (background strain)
mice for baseline PPI to a 119 dB startle pulse with 73, 77, and 85 dB prepulses. The
mice were re-evaluated 2, 9, and 16-d post-DOX administration. Locomotor activity
was also assessed in a 2-h test session in naïve Tat transgenic mice. Baseline PPI was
not significantly different between groups; however, PPI significantly decreased in
Tat(+)/DOX after 2, 9, and 16-d of DOX administration (p#0.05). PPI was unaltered
in DOX-treated Tat(-) and C57BL/6J mice, indicating a lack of nonspecific DOX
effects. PPI was also unaltered in untreated Tat(+), Tat(-), and C57BL/6J mice. In
locomotor activity tests, baseline total distance traveled was not significantly different
between groups, however after DOX administration, Tat(+)/DOX mice traveled
significantly less than Tat(-)/DOX mice (p#0.05). These results suggest that HIV Tat
induction caused sensorimotor gating and locomotor deficits in mice, which may serve
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as predictive correlates of some aspects of the behavioral and motor pathology
associated with HAND.
MITOCHONDRIAL DYSFUNCTION IN STREPTOZOTOCIN ALZHEIMER’S
DISEASE MODEL. Essie S. Komla1 , Ann C. Rice 1 , Paula I. Moreira 2 , & James P.
Bennett Jr.1 , 1 Parkinson’s and Movement Disorders Center, Virginia Commonwealth
University, Richmond, VA 23298 & 2 Center for Neuroscience and Cell Biology of
Coimbra, University of Coimbra, 3030 Coimbra, Portugal. Alzheimer’s disease (AD)
is the most common type of dementia found in the adult population. The disease is
characterized by death or malfunction of neurons leading to memory loss, cognitive
decline, and increased level of amyloid beta peptides and neurofibrillary tangles. Some
researchers suggest AD is an “insulin-resistant brain state” disorder and the use of
intracerebroventricular (icv) injection of streptozotocin (STZ) in rats is emerging as an
experimental model for the disease. W e hypothesize we will observe increased
expression of mitochondrial biogenesis markers in the icvSTZ rats as a compensatory
response to decreased metabolism. Using laser capture microdissection (LCM) to
collect multiple groups of 20 hippocampal pyramidal neurons, we determined the
mitochondrial DNA (mtDNA) copy numbers from 5 icvSTZ rats and 4 control (CTL)
cases using quantitative polymerase chain reaction (qPCR). W e found no significant
difference between the mtDNA copy numbers of the STZ samples compared to the
control. However, these preliminary data show a trend toward increased mtDNA copy
numbers in STZ treated brain which is one of the biomarkers of mitochondrial
biogenesis. In conclusion, our preliminary data show an increase in mitochondrial gene
copy numbers as the cells try to compensate for the degeneration of the neurons;
thereby, increasing mitochondrial synthesis.
THERAPEUTIC EFFICACY OF COMBINATION OF MTOR INHIBITORS AND
AMPK ACTIVATORS IN NON-SMALL CELL LUNG CANCER. Grinal M. Corriea
& Richard G. Moran, Dept. of Pharmacology & Toxicology, Richmond, VA 23298.
Pemetrexed (PTX), an antifolate drug, has been approved by the FDA for first line
therapy of mesothelioma and non-small cell lung cancer. In addition to its primary site
of action on thymidylate synthase, PTX also inhibits the second folate-dependent
enzyme of purine biosynthesis, aminoimidazolecarboxamide ribonucleotide
formyltransferase (AICART). Accumulation of AICART substrate, ZMP in PTXinhibited cancer cells leads to downstream activation of AMP-activated protein kinase
(AMPK) with subsequent inhibition of mammalian target of rapamycin (mTOR) and
hyperphosphorylation of its downstream targets responsible for protein synthesis and
cell proliferation. Inhibitors of mTORC1 like Rapamycin and its analogs have only
partial effect, as they do not inhibit mTORC2, which phosphorylates Akt subsequently
relieving the inhibition of mTORC1and leading to poor cytotoxicity. AZD8055 is an
ATP-competitive inhibitor of mTOR kinase and potently inhibits both mTORC1 and
mTORC2. Our data shows that AMPK activation via PTX-mediated AICART
inhibition in combination with direct mTOR inhibition by AZD8055 has a synergistic
interaction on the proliferation of cells in culture. Activators of AMPK enhance the
effects of direct inhibitors of mTOR and vice-versa and these effects are mediated via
combined effects on mTORC1. Taken together, it is a promising therapeutic strategy.
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SENSITIZATION OF NON-SMALL CELL LUNG CANCER (NSCLC) TO
RADIATION BY VITAMIN D BY A CYTOSTATIC FORM OF AUTOPHAGY. K.
Sharma, R. W . Goehe, X. Di, S. Torti, F. Torti & D. A. Gewirtz, Dept. of Pharm. &
Tox., VCU, Richmond, VA 23298. The standard of care for unresectable lung cancer
is chemoradiation. However, therapeutic options are limited and patients are rarely
cured. In A549 and H460 non-small cell lung cancer (NSCLC) cells, 1,25-D 3 (the
hormonally active form of vitamin D) and EB 1089 prolonged the growth arrest
induced by radiation alone and suppressed proliferative recovery, which translated to
a significant reduction in clonogenic survival. In H838 or H358 NSCLC cells, which
lack the vitamin D receptor or functional p53, respectively, 1,25-D 3 failed to modify
the extent of radiation-induced growth arrest. Sensitization to radiation in H1299
NSCLC cells was evident only when p53 was induced in otherwise p53 null H1299
NSCLC cells. Sensitization was not associated with increased DNA damage or an
increase in apoptosis, necrosis or senescence. Instead sensitization appeared to be a
consequence of the conversion of the cytoprotective autophagy induced by radiation
alone to a novel cytostatic form of autophagy by the combination of vitamin D with
radiation. W hile both pharmacological and genetic suppression of autophagy or
inhibition of AM PK phosphorylation sensitized the NSCLC cells to radiation alone,
inhibition of the cytostatic autophagy induced by the combination treatment reversed
sensitization. Taken together, these studies have identified a unique cytostatic function
of autophagy that appears to be mediated by the vitamin D receptor, p53 and AMPK
in the promotion of an enhanced response to radiation by 1,25-D 3 and EB 1089 in
NSCLC.
CHRONIC MORPHINE ENHANCES NICOTINE RESPONSES IN SINGLE MOUSE
ENTERIC NEURONS. Aravind R. Gade, W illiam L. Dewey and Hamid I. Akbarali,
Deptartment of Pharmacology & Toxicology, Virginia Commonwealth University,
Richmond, VA 23298. Opioids are excellent pain relievers. A major side-effect of
chronic opioid treatment is constipation whereas withdrawal following chronic
exposure leads to diarrhea and increased gastrointestinal motility. These effects of
chronic opioids are mediated by mu opioid receptors expressed on enteric neurons.
Previous in-vitro studies have shown that chronic opioids enhance sensitivity to
nicotinic receptor agonists. In this study we examined the sensitivity to nicotine
following short (10 minutes) and long-term exposure (16-20 hours) to morphine in
isolated mouse single enteric neurons using patch-clamp techniques. Nicotine (1mM)
induced inward currents from holding potential of -60 mV that were significantly
increased in neurons exposed for long-term but not short-term to morphine. However
a significant shift was not seen in the EC (50) values in all neurons. The maximal
current densities induced by 1mM nicotine were 168 ± 29 pA/pF, 135 ± 31 and 296 ±
51 pA/pF in control, short-term and long-term morphine treated cells respectively, and
the EC (50) values were 44 ± 17 µM (n = 9), 42 ± 14 (n = 5) and 26 ± 7 µM (n = 11)
in the same order. Shift in the maximal currents but not in the EC (50) values suggests
a shift in the efficacy but not potency of nicotine after long term exposure to morphine.
Studying the mechanisms involved in this enhancement is hypothesized to give a better
insight into methods for treating opioid dependent and withdrawal symptoms.
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